Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.81 | N/A |
| PEG Ratio (TTM) | 3.51 | N/A |
| P/S Ratio (TTM) | 1.73 | N/A |
| P/B Ratio (TTM) | 1.18 | N/A |
| P/FCF Ratio (TTM) | 14.58 | N/A |
| Price to 5YR AVG Earnings Ratio | 10.18 | N/A |
| Price to 5YR AVG FCF Ratio | 9.49 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.74% | N/A |
| ROE (TTM) | 9.89% | N/A |
| Net Profit Margin (TTM) | 13.61% | N/A |
| ROIC 5YR AVG | -35.61% | N/A |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 9.46% | 31.42% | 14.63% |
| Revenue | 7.00% | 2.85% | 2.71% |
| Net Income | 9.48% | 23.08% | 7.26% |
| Cash Flow | 44.74% | 9.18% | -0.77% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.05 | N/A |
| Quick Ratio (TTM) | 2.05 | N/A |
| D/E Ratio (TTM) | 0.16 | N/A |
| Interest Coverage (TTM) | 0.72 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.56 | N/A |
| LTL to 5YR AVG FCF | 1.60 | N/A |
| Shares Outstanding Growth 5YR AVG | -6.61% | N/A |